Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pain-drug market to stagnate on generic erosion, report says
Fierce Pharma
Monday, December 5, 2011 - 12:27pm
tags:
generics, painkillers, Pfizer, Lyrica, Purdue, oxycontin, Celebrex, Eli Lilly, Cymbalta
FACTBOX-Stem cell advances focus on heart, inflammation
Reuters
Monday, December 5, 2011 - 12:25pm
tags:
stem cells, inflammation, Aastrom, Arthersys, Baxter, Celgene, Cytori, Mesoblast, Fibrocell Science, StemCells, Pluristem, Osiris, Pharmicell, NeoStem, Neuralstem, Gamida Cell
Shire reaches deal for additional ProAmatine trials
Pharma Times, UK
Monday, December 5, 2011 - 12:16pm
tags:
ProAmatine, Shire, hypotension
The Death Of The Sales Rep Is Greatly Exaggerated
Pharmalot
Monday, December 5, 2011 - 12:12pm
tags:
drug reps, physicians
Pfizer tactics to combat generic drug makers
FT.com
Monday, December 5, 2011 - 12:11pm
tags:
generics, Pfizer, Lipitor
Drug research calls for shot of vitality
FT.com
Monday, December 5, 2011 - 10:47am
tags:
R&D, Xenetic Biosciences
Icahn’s $2 Billion Man Starts Fund as Activists Shun Biotech
Bloomberg
Monday, December 5, 2011 - 10:46am
tags:
Carl Icahn, biotech, Alex Denner
Abbott to Invest More in R&D in Emerging Markets, CEO Says
Bloomberg
Monday, December 5, 2011 - 9:32am
tags:
R&D, Abbott Laboratories, Pharma CEOs, emerging markets, Miles White
Abbott dismisses talk of pharma unit sale
Reuters
Monday, December 5, 2011 - 9:31am
tags:
Abbott Laboratories, M&A
Pfizer’s Kidney Cancer Drug May Not Be Effective, FDA Says
Bloomberg
Monday, December 5, 2011 - 9:31am
tags:
FDA, Pfizer, kidney cancer, Axitinib
GenericsWeb Analyses Generic Opportunities for Merck’s Blockbuster Ezetimibe
PR NewsWire
Saturday, December 3, 2011 - 4:09pm
tags:
Merck, Ezetimibe, cholesterol
Amherst-Based Pharmaceutical Company Files Federal Lawsuit Accusing Competitor of False Claims Regarding the Efficacy of Infasurf®, its Life-Saving Respiratory Drug for Premature Infants
Sacramento Bee, Ca
Saturday, December 3, 2011 - 4:07pm
tags:
Infasurf, ONY Inc, Cornerstone Therapeutics, Curosurf, respiratory distress
Ranbaxy's silence on Teva profit-sharing draws questions
FiercePharma
Saturday, December 3, 2011 - 4:03pm
tags:
Ranbaxy, Teva Pharmaceuticals
Micro cap biotech trading well below cash value
Stockhouse
Saturday, December 3, 2011 - 4:02pm
tags:
Thallion Pharmaceuticals
Biopharma's dirty secret revealed
Forbes
Saturday, December 3, 2011 - 3:58pm
tags:
R&D
Drugmakers target hepatitis C
Yahoo/Investor's Business Daily
Saturday, December 3, 2011 - 3:57pm
tags:
Tibotec, Bristol-Myers Squibb, JNJ, hepatitis C, TMC435, declatasvir. Ribavirin, interferon
Idenix Pharmaceuticals Shares Surged: What You Need to Know
Motley Fool
Saturday, December 3, 2011 - 3:54pm
tags:
Idenix, IDX184, hepatitis C
One More Thought About Lipitor
Forbes
Saturday, December 3, 2011 - 3:53pm
tags:
Pfizer, Lipitor
The Law Firm of Levi & Korsinsky Launches an Investigation Into Possible Breaches of Fiduciary Duties and Unjust Enrichment by the Board of Directors of Abbott Laboratories, Inc.
Yahoo/PR NewsWire
Saturday, December 3, 2011 - 3:51pm
tags:
Abbott Laboratories, lawsuits
Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer Treatments
Forbes
Saturday, December 3, 2011 - 3:50pm
tags:
Spectrum Pharmaceuticals, Zevalin, non-Hodgkin's lymphoma, osteosarcoma, Fusilev

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.